The Business Magazine - B2B Business News - Site Logo

Warning: Undefined array key "selectissue" in /home/970822.cloudwaysapps.com/utkbfqnuhr/public_html/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 4

Warning: Undefined array key "tbm_visit_edition_me" in /home/970822.cloudwaysapps.com/utkbfqnuhr/public_html/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 22
The Business Magazine - B2B Business News - Site Logo
The Business Magazine May 2024
Read now
PICK YOUR EDITION

Extra £47.6 million for Oxfordshire's Vaccines Manufacturing and Innovation Centre

The Business Magazine article image for: Extra £47.6 million for Oxfordshire's Vaccines Manufacturing and Innovation Centre
23 March 2021

The Vaccines Manufacturing and Innovation Centre (VMIC), which is being built at Harwell Campus in Oxfordshire, has been granted an additional £47.6 million to support the expansion and acceleration of the programme.

The VMIC will be the UK’s first national vaccines manufacturing and innovation facility and will be able to respond to pandemics by producing millions of doses quickly.

The funding will support work already underway to expand the capacity twenty-fold so that the UK has a highly specialist manufacturing centre that, in a pandemic situation, can make up to 70 million doses within a 6 month period and accelerate the timeline for VMIC to be operationally ready so it can support the national response to (coronavirus) COVID-19

VMIC has been granted almost £215 million of government funding in total to date.

In May 2020, the government confirmed additional funding of £93 million to the VMIC - which was first announced in 2018 - to expand and fast track the project. The new £47.6 million is in addition to this funding and will support the delivery of this highly specialist facility during these unprecedented, challenging times.

Through the VMIC, the government also invested £8.75 million in the set-up of a rapid deployment facility at Oxford Biomedica in Oxfordshire, which was a major milestone in increasing UK manufacturing capability of viral vector vaccines. By October 2020, these 2 additional manufacturing sites were approved by the Medicines and Healthcare Products Regulatory Agency, and are currently producing the Oxford University/AstraZeneca vaccine.

https://www.businessinnovationmag.co.uk/boris-inspects-build-progress-at-harwells-vaccine-manufacturing-and-innovation-centre/


Share 

Nicky Godding is editor of The Business Magazine. Before her journalism career, she worked mainly in public relations moving into writing when she was invited to launch Retail Watch, a publication covering retail and real estate across Europe.

After some years of constant travelling, she tucked away her passport and concentrated on business writing, co-founding a successful regional business magazine. She has interviewed some of the UK’s most successful entrepreneurs who have built multi-million-pound businesses and reported on many science and technology firsts.

She reports on the region’s thriving business economy from start-ups, family businesses and multi-million-pound corporations, to the professionals that support their growth and the institutions that educate the next generation of business leaders.

Latest deal ticket

All deals
  • Gristwood & Toms (Hertfordshire)
    has been acquired by
    Nurture Group (Surrey)
    June 2024
    UNDISCLOSED
    Who's behind the deal?
  • OnSecurity (Bristol)
    has secured investment from
    Gresham House Ventures (London)
    June 2024
    £5.5m
    Who's behind the deal?
  • Two Cedars Care Home (Dorset)
    has been acquired by
    Serenata Care (Dorset)
    June 2024
    UNDISCLOSED
    Who's behind the deal?

Events

All events

Related news


Group Titles

Dorset BIZ NewsHampshire BIZ News
cross